AVD-275

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameAVD-275
Drug Alias NameLong-acting formulation of celecoxib (Avidence Therapeutics)AVD275AVD-275
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAvidence Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvidence Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A